EVALUATION OF THE ROLE OF HYPERHOMOCYSTEINEMIA AND POLYMORPHISM C677T GENE OF METHYLTETRAHYDROFOLATEREDUCTASE IN DEVELOPMENT OF CHRONIC HEART FAILURE

EVALUATION OF THE ROLE OF HYPERHOMOCYSTEINEMIA AND POLYMORPHISM C677T GENE OF METHYLTETRAHYDROFOLATEREDUCTASE IN DEVELOPMENT OF CHRONIC HEART FAILURE

Aim. To study the influence of polymorphism of the gene methyltetrahydrofolate-reductase (MTHFR) — polymorhic locus С677Т, and level of homocysteine in blood plasma on the risk of development and course of chronic heart failure (CHF).Material and methods. Totally, 277 persons studied with CHF II-...

Full description

Bibliographic Details
Main Authors:	A. T. Teplyakov, E. N. Berezikova, S. N. Shilov, E. V. Grakova, Yu. Yu. Torim, A. V. Efremov, А. А. Popova, М. G. Pustosvetova, А. Yu. Sabirova, К. V. Kopieva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2016-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	сердечная недостаточность гомоцистеин метилентетрагидрофолатредуктаза полиморфизм с677т
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/443

Similar Items

Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

Hyperhomocysteinemia, C-677T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene, and chronic arterial hypertension in pregnant women
by: V. S. Chulkov, et al.
Published: (2012-02-01)

The polymorphism c677t of the gene MTHFR correlates with the complications of the coronary heart disease and arterial hypertension for the patients with dislipidaemia
by: G I Myandina, et al.
Published: (2012-06-01)

ВЛИЯНИЕ ПОЛИМОРФИЗМА ГЕНА КАСПАЗЫ 8 НА РИСК РАЗВИТИЯ И ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

Influence of endothelial NO synthase gene polymorphisms on development and prognosis of chronic heart failure
by: N. F. Yakovleva, et al.
Published: (2008-10-01)

ВЛИЯНИЕ АПОПТОЗА НА ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Ye. N. Berezikova, et al.
Published: (2015-10-01)

Hyperhomocysteinemia in children with pyelonephritis
by: O. V. Nesterenko, et al.
Published: (2016-09-01)

Clinical use of the new biomarker ST2 in patients with chronic heart failure of ischemic genesis: an exercise test
by: E. V. Grakova, et al.
Published: (2019-09-01)

EARLY MARKERS OF PROGRESSION OF HEART FAILURE AND APOPTOSIS: THEIR ROLE IN PREDICTING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION
by: A. T. Teplyakov, et al.
Published: (2016-03-01)

Factors determining homocysteine levels in Russian patients with stable coronary heart disease
by: O. O. Shakhmatova, et al.
Published: (2010-08-01)

Pathogenesis of chronic heart failure: change of dominating paradigm
by: V. V. Kalyuzhin, et al.
Published: (2007-12-01)

Osteoprotegerin is a new independent predictor of the progression of cardiovascular pathology: chronic heart failure associated with type 2 diabetes and osteoporosis
by: A. T. Teplyakov, et al.
Published: (2018-12-01)

ЦИТОКИНОВЫЙ ПРОФИЛЬ ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Ye. N. Berezikova, et al.
Published: (2015-10-01)

Indicators of a hemostasis in patients with hyperhomocysteinemia on a hemodialysis
by: U. V. Kharlamova, et al.
Published: (2011-02-01)

Prognostic value of hypoxia-inducible factor-1 alpha gene polymorphism in patients with heart failure with preserved ejection fraction and obstructive sleep apnea
by: A. V. Yakovlev, et al.
Published: (2022-08-01)

ОСТРАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ. ЕВРОПЕЙСКИЙ КОНСЕНСУС: ПЕРЕВОД РЕКОМЕНДАЦИЙ
by: Н. Т. Ватутин, et al.
Published: (2015-08-01)

NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE
by: N. I. Tarasov, et al.
Published: (2016-06-01)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

PROGNOSTIC SIGNIFICANCE OF THE VNTR POLYMORPHISM INTRON 4 OF THE GENE OF NITRIC OXIDE ENDOTHELIAL SYNTHASE IN CHRONIC HEART FAILURE PATIENTS
by: E. A. Polunina, et al.
Published: (2018-02-01)

Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization
by: E. V. Grakova, et al.
Published: (2018-10-01)

Первый опыт расширенной миоэктомии при хирургическом лечении обструктивной гипертрофической кардиомиопатии: непосредственные и промежуточные результаты
by: А. В. Богачев-Прокофьев, et al.
Published: (2015-10-01)

ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ И АНЕМИЯ: РОЛЬ ДЕФИЦИТА ЖЕЛЕЗА И ЕГО КОРРЕКЦИЯ
by: А. М. Шилов, et al.
Published: (2012-02-01)

Hyperhomocysteinemia and its correction in posttrombotic syndrome of the lower limbs
by: R E Kalinin, et al.
Published: (2016-12-01)

Predictors of an adverse course of heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome
by: A. T. Teplyakov, et al.
Published: (2021-07-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
by: M. V. Melnik, et al.
Published: (2015-12-01)

PREDICTIVE VALUE OF CARDIAC CACHEXIA IN CHRONIC HEART FAILURE
by: E. S. Drobysheva, et al.
Published: (2016-08-01)

Подкожные кардиовертеры-дефибрилляторы в сравнении с трансвенозными: 6-месячное наблюдение
by: А.В. Верещагина, et al.
Published: (2023-03-01)

Диссинхрония миокарда у больных с хронической сердечной недостаточностью: факторы, влияющие на развитие, особенности коррекции
by: А. И. Чесникова, et al.
Published: (2011-04-01)

Hyperhomocysteinemia and lipid peroxidation in stable coronary heart disease
by: O. L. Belaya, et al.
Published: (2007-02-01)

KEY PATHOGENETIC ASPECTS AND CLINICAL RELEVANCE OF MECHANICAL DYSSYNCHRONY
by: Yu. V. Stavtseva, et al.
Published: (2015-09-01)

Modern concept of diastolic heart failure
by: F. T. Ageev
Published: (1970-01-01)

The distribution of allelic variants in the folate cycle enzyme genes and the level of homocysteine in patients with congenital heart disease and functional single ventricle
by: Yu. G. Lugacheva, et al.
Published: (2016-03-01)

Hyperhomocysteinemia and C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene in Patients with Cardiovascular Disease
by: Houcher Zahira, et al.
Published: (2010-02-01)

Genetic testing for forecasting and course of the chronic heart failure against the background arterial hypertension
by: A. L. Khokhlov, et al.
Published: (2018-02-01)

Functional morphology of heart at experimental influences and possibility of regress of destructive changes of the myocardium against introduction of preparations
by: L G Proshina, et al.
Published: (2009-12-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

The role of cardiomyocyte apoptosis in mechanisms of ischemic myocardial remodeling
by: A. P. Khlapov, et al.
Published: (2008-09-01)

Mitral valve replacement or repair: choosing optimal surgical treatment of hypertrophic obstructive cardiomyopathy
by: Богачев-Прокофьев А. В., et al.
Published: (2016-01-01)

Pathogenesis of Cardiac Depression in Acute Destructive Pancreatitis
by: A. V. Ershov, et al.
Published: (2016-02-01)

Melatonin and cardiovascular disease: from mechanisms of action to potential clinical use (literature review)
by: O. M. Drapkina, et al.
Published: (2022-01-01)